niclosamide has been researched along with Anosmia in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Anosmia: Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernandez-Clavijo, A | 1 |
| Gonzalez-Velandia, KY | 1 |
| Rangaswamy, U | 1 |
| Guarneri, G | 1 |
| Boscolo-Rizzo, P | 1 |
| Tofanelli, M | 1 |
| Gardenal, N | 1 |
| Sanges, R | 1 |
| Dibattista, M | 1 |
| Tirelli, G | 1 |
| Menini, A | 1 |
1 other study available for niclosamide and Anosmia
| Article | Year |
|---|---|
Supporting Cells of the Human Olfactory Epithelium Co-Express the Lipid Scramblase TMEM16F and ACE2 and May Cause Smell Loss by SARS-CoV-2 Spike-Induced Syncytia.
Topics: Angiotensin-Converting Enzyme 2; Anosmia; COVID-19; Giant Cells; Humans; Lipids; Niclosamide; Olfact | 2022 |